Literature for S17092 (S09.001 inhibitor)

(Topics flags: T Target, K Knockout, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2018
1. Chan,G.C.W., Wu,H.J., Chan,K.W., Yiu,W.H., Zou,A., Huang,X.R., Lan,H.Y., Lai,K.N. and Tang,S.C.W.
   N-Acetyl-seryl-aspartyl-lysyl-proline mediates the anti-fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice
   Nephrology (Carlton)23, 297-307. PubMed  Europe PubMed DOI  I
2. Fu,P., Sun,W., Lai,J., Shen,Y.H. and Zhang,Z.
   Identification of two isoforms of Pop in the domestic silkworm, Bombyx mori: cloning, characterization and expression analysis
   Gene667, 101-111. PubMed  Europe PubMed DOI  I
2017
3. Zhou,D., Wang,J., He,L.N., Li,B.H., Ding,Y.N., Chen,Y.W. and Fan,J.G.
   Prolyl oligopeptidase attenuates hepatic stellate cell activation through induction of Smad7 and PPAR-gamma
   Exp Ther Med13, 780-786. PubMed  Europe PubMed DOI  I
2016
4. Zhou,D., Li,B.H., Wang,J., Ding,Y.N., Dong,Y., Chen,Y.W. and Fan,J.G.
   Prolyl oligopeptidase inhibition attenuates steatosis in the L02 human liver cell line
   PLoS ONE11, e0165224-e0165224. PubMed  Europe PubMed DOI  I
2014
5. Kim,J.D., Toda,C., D'Agostino,G., Zeiss,C.J., DiLeone,R.J., Elsworth,J.D., Kibbey,R.G., Chan,O., Harvey,B.K., Richie,C.T., Savolainen,M., Myohannen,T., Jeong,J.K. and Diano,S.
   Hypothalamic prolyl endopeptidase (PREP) regulates pancreatic insulin and glucagon secretion in mice
   Proc Natl Acad Sci U S A111, 11876-11881. PubMed  Europe PubMed DOI  K  I
2010
6. Li,P., Xiao,H.D., Xu,J., Ong,F.S., Kwon,M., Roman,J., Gal,A., Bernstein,K.E. and Fuchs,S.
   Angiotensin-converting enzyme N-terminal inactivation alleviates bleomycin-induced lung injury
   Am J Pathol177, 1113-1121. PubMed  Europe PubMed DOI  K  I
2006
7. [YEAR:4-1-2006]Leprince,J., Cosquer,D., Bellemere,G., Chatenet,D., Tollemer,H., Jegou,S., Tonon,M.C. and Vaudry,H.
   Catabolism of the octadecaneuropeptide ODN by prolyl endopeptidase: identification of an unusual cleavage site
   Peptides27, 1561-1569. PubMed  Europe PubMed DOI  T  I
2004
8. Cavasin,M.A., Rhaleb,N.E., Yang,X.P. and Carretero,O.A.
   Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP
   Hypertension43, 1140-1145. PubMed  Europe PubMed DOI  I
2003
9. Bellemere,G., Morain,P., Vaudry,H. and Jegou,S.
   Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and alpha-melanocyte-stimulating hormone breakdown in the rat brain
   J Neurochem84, 919-929. PubMed  Europe PubMed DOI  T  I
2002
10. Morain,P., Lestage,P., de Nanteuil,G., Jochemsen,R., Robin,J.L., Guez,D. and Boyer,P.A.
    S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies
    CNS Drug Rev8, 31-52. PubMed  Europe PubMed  T  I
11. [YEAR:13-2-2002]Odaka,C., Mizuochi,T., Shirasawa,T., Morain,P. and Checler,F.
    Murine T cells expressing high activity of prolyl endopeptidase are susceptible to activation-induced cell death
    FEBS Lett512, 163-167. PubMed  Europe PubMed DOI  I
12. Schneider,J.S., Giardiniere,M. and Morain,P.
    Effects of the prolyl endopeptidase inhibitor S 17092 on cognitive deficits in chronic low dose MPTP-treated monkeys
    Neuropsychopharmacology26, 176-182. PubMed  Europe PubMed DOI  T  I
2001
13. Hasebe,T., Hua,J., Someya,A., Morain,P., Checler,F. and Nagaoka,I.
    Involvement of cytosolic prolyl endopeptidase in degradation of p40-phox splice variant protein in myeloid cells
    J Leukoc Biol69, 963-968. PubMed  Europe PubMed  I
2000
14. Marighetto,A., Touzani,K., Etchamendy,N., Torrea,C.C., de Nanteuil,G., Guez,D., Jaffard,R. and Morain,P.
    Further evidence for a dissociation between different forms of mnemonic expressions in a mouse model of age-related cognitive decline: effects of tacrine and S 17092, a novel prolyl endopeptidase inhibitor
    Learn Mem7, 159-169. PubMed  Europe PubMed DOI  I
15. Morain,P., Robin,J.L., de Nanteuil,G., Jochemsen,R., Heidet,V. and Guez,D.
    Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I study
    Br J Clin Pharmacol50, 350-359. PubMed  Europe PubMed DOI  I
1999
16. [YEAR:21-4-1999]Barelli,H., Petit,A., Hirsch,E., Wilk,S., de Nanteuil,G., Morain,P. and Checler,F.
    S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase
    Biochem Biophys Res Commun257, 657-661. PubMed  Europe PubMed DOI  I
1996
17. [YEAR:7-6-1996]Portevin,B., Benoist,A., Remond,G., Herve,Y., Vincent,M., Lepagnol,J. and de Nanteuil,G.
    New prolyl endopeptidase inhibitors: in vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives
    J Med Chem39, 2379-2391. PubMed  Europe PubMed DOI  T  I